Abstract
Insulin and insulin-like growth factor 1 (IGF-1) receptors are ubiquitously expressed and regulate cell growth, survival, and function. In insulin-secreting cells, they contribute to proper insulin synthesis and secretion, as well as to overall pancreatic β-cell survival. The most convincing proof of the importance of these signalling pathways came from mice deficient in insulin receptors, IGF-1 receptors, or insulin receptor substrate-2 (IRS-2). Knockout of the insulin receptor or IRS-2 leads to life-threatening hyperglycemia and is prevented by β-cell-specific expression of IRS-2. Pancreatic β-cells exist in an insulin-rich environment, and therefore, the regulation and activation of their receptors must differ from cells in peripheral insulin-sensitive tissues. Intriguingly, the downstream signalling of these receptors diverges towards anti- and proapoptotic pathways: receptor activation improves cell function and growth but also induces feedback inhibition and apoptosis. This chapter summarizes current understanding of insulin and IGF-1 receptor regulation; signalling and function in β-cells with special emphasis on the regulation of insulin receptor substrates, IRS-1 and IRS-2; downstream kinases; and feedback mechanisms that impair β-cell function.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Accili D (1995) Molecular defects of the insulin receptor gene. Diabetes Metab Rev 11:47–62
Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106–109
Alejandro EU, Kalynyak TB, Taghizadeh F, Gwiazda KS, Rawstron EK, Jacob KJ, Johnson JD (2010) Acute insulin signaling in pancreatic β-cells is mediated by multiple Raf-1 dependent pathways. Endocrinology 151:502–512
Alenzi FQ (2004) Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci 61:99–102
Alliouachene S, Tuttle RL, Boumard S, Lapointe T, Berissi S, Germain S, Jaubert F, Tosh D, Birnbaum MJ, Pende M (2008) Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest 118:3629–3638
Ammon HP, Reiber C, Verspohl EJ (1991) Indirect evidence for short-loop negative feedback of insulin secretion in the rat. J Endocrinol 128:27–34
Aoyagi K, Ohara-Imaizumi M, Nishiwaki C, Nakamichi Y, Ueki K, Kadowaki T, Nagamatsu S (2012) Acute inhibition of PI3K-PDK1-Akt pathway potentiates insulin secretion through upregulation of newcomer granule fusions in pancreatic β-cells. PLoS One 7(10):e47381
Argoud GM, Schade DS, Eaton RP (1987) Insulin suppresses its own secretion in vivo. Diabetes 36:959–962
Aspinwall CA, Lakey JR, Kennedy RT (1999a) Insulin-stimulated insulin secretion in single pancreatic β cells. J Biol Chem 274:6360–6365
Aspinwall CA, Huang L, Lakey JR, Kennedy RT (1999b) Comparison of amperometric methods for detection of exocytosis from single pancreatic β-cells of different species. Anal Chem 71:5551–5556
Aspinwall CA, Qian WJ, Roper MG, Kulkarni RN, Kahn CR, Kennedy RT (2000) Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in β -cells. J Biol Chem 275:22331–22338
Avram D, Ranta F, Hennige AM, Berchtold S, Hopp S, Häring HU, Lang F, Ullrich S (2008) IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation. Cell Physiol Biochem 21:455–462
Benes C, Poitout V, Marie JC, Martin-Perez J, Roisin MP, Fagard R (1999) Mode of regulation of the extracellular signal-regulated kinases in the pancreatic β-cell line MIN6 and their implication in the regulation of insulin gene transcription. Biochem J 340:219–225
Bennett RG, Hamel FG, Duckworth WC (2003) An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes 52:2315–2320
Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA (2004) Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β cells. J Clin Invest 114:928–936
Borge PD Jr, Wolf BA (2003) Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting β-cells. J Biol Chem 278:11359–11368
Bouche C, Lopez X, Fleischman A, Cypess AM, O’Shea S, Stefanovski D, Bergman RN, Rogatsky E, Stein DT, Kahn CR, Kulkarni RN, Goldfine AB (2010) Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci USA 107:4770–4775
Braun M, Ramracheya R, Johnson PR, Rorsman P (2009) Exocytotic properties of human pancreatic β-cells. Ann N Y Acad Sci 1152:187–193
Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic β-cells. Diabetes 52:974–983
Briaud I, Dickson LM, Lingohr MK, McCuaig JF, Lawrence JC, Rhodes CJ (2005) Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in β-cells. J Biol Chem 280:2282–2293
Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561–572
Buteau J, Accili D (2007) Regulation of pancreatic β-cell function by the forkhead protein FoxO1. Diabetes Obes Metab 9(Suppl 2):140–146
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Cantley J, Choudhury AI, Asare-Anane H, Selman C, Lingard S, Heffron H, Herrera P, Persaud SJ, Withers DJ (2007) Pancreatic deletion of insulin receptor substrate 2 reduces β and α cell mass and impairs glucose homeostasis in mice. Diabetologia 50:1248–1256
Cantley J, Boslem E, Laybutt DR, Cordery DV, Pearson G, Carpenter L, Leitges M, Biden TJ (2011) Deletion of protein kinase Cdelta in mice modulates stability of inflammatory genes and protects against cytokine-stimulated β cell death in vitro and in vivo. Diabetologia 54:380–389
Carpentier JL (1994) Insulin receptor internalization: molecular mechanisms and physiopathological implications. Diabetologia 37(Suppl 2):S117–S124
Chambard JC, Lefloch R, Pouyssegur J, Lenormand P (2007) ERK implication in cell cycle regulation. Biochim Biophys Acta 1773:1299–1310
Copps KD, White MF (2012) Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55:2565–2582
da Silva X, Varadi A, Ainscow EK, Rutter GA (2000) Regulation of gene expression by glucose in pancreatic β-cells (MIN6) via insulin secretion and activation of phosphatidylinositol 3′-kinase. J Biol Chem 275:36269–36277
da Silva X, Qian Q, Cullen PJ, Rutter GA (2004) Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic β-cell glucose sensing revealed by RNA silencing. Biochem J 377:149–158
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241
De Meyts P (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37(Suppl 2):S135–S148
Demozay D, Tsunekawa S, Briaud I, Shah R, Rhodes CJ (2011) Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells. Diabetes 60:2892–2902
Dominguez V, Raimondi C, Somanath S, Bugliani M, Loder MK, Edling CE, Divecha N, da Silva-Xavier G, Marselli L, Persaud SJ, Turner MD, Rutter GA, Rutter GA, Falasca M, Maffucci T (2011) Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic β cells. J Biol Chem 286:4216–4225
Düfer M, Haspel D, Krippeit-Drews P, Aguilar-Bryan L, Bryan J, Drews G (2009) Activation of the Na+/K+-ATPase by insulin and glucose as a putative negative feedback mechanism in pancreatic β-cells. Pflugers Arch 457:1351–1360
Elahi D, Nagulesparan M, Hershcopf RJ, Müller DC, Tobin JD, Blix PM, Rubenstein AH, Unger RH, Andres R (1982) Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 306:1196–1202
Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E (2007) Regulation of β-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 9(Suppl 2):147–157
Elghazi L, Bernal-Mizrachi E (2009) Akt and PTEN: β-cell mass and pancreas plasticity. Trends Endocrinol Metab 20:243–251
Elghazi L, Balcazar N, Blandino-Rosano M, Cras-Meneur C, Fatrai S, Gould AP, Chi MM, Moley KH, Bernal-Mizrachi E (2010) Decreased IRS signaling impairs β-cell cycle progression and survival in transgenic mice overexpressing S6K in β-cells. Diabetes 59:2390–2399
Eto K, Yamashita T, Tsubamoto Y, Terauchi Y, Hirose K, Kubota N, Yamashita S, Taka J, Satoh S, Sekihara H, Tobe K, Iino M, Noda M, Kimura S, Kadowaki T (2002) Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca2+] elevation signals. Diabetes 51:87–97
Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162–4167
Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E (2006) Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318–325
Federici M, Hribal ML, Ranalli M, Marselli L, Porzio O, Lauro D, Borboni P, Lauro R, Marchetti P, Melino G, Sesti G (2001) The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 15:22–24
Fei H, Zhao B, Zhao S, Wang Q (2008) Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1β-induced β-cell apoptosis. Mol Cell Biochem 315:75–84
Florez JC, Wiltshire S, Agapakis CM, Burtt NP, de Bakker PI, Almgren P, Bengtsson BK, Tuomi T, Gaudet D, Daly MJ, Hirschhorn JN, McCarthy MI, Altshuler D, Groop L (2006) High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes 55:128–135
Folli F, Okada T, Perego C, Gunton J, Liew CW, Akiyama M, D’Amico A, La Rosa S, Placidi C, Lupi R, Marchetti P, Sesti G, Hellerstein M, Perego L, Kulkarni RN (2011) Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus. PLoS ONE 6:e28050
Frerichs H, Reich U, Creutzfeldt W (1965) Insulin secretion in vitro. I. Inhibition of glucose-induced insulin release by insulin. Klin Wochenschr 43:136–140
Freychet P, Roth J, Neville DM Jr (1971) Insulin receptors in the liver: specific binding of (125 I) insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci USA 68:1833–1837
Fritsche L, Neukamm SS, Lehmann R, Kremmer E, Hennige AM, Hunder-Gugel A, Schenk M, Häring HU, Schleicher ED, Weigert C (2011) Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907. Am J Physiol Endocrinol Metab 300:E824–E836
German MS, Moss LG, Rutter WJ (1990) Regulation of insulin gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem 265:22063–22066
Giraud J, Leshan R, Lee YH, White MF (2004) Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J Biol Chem 279:3447–3454
Glebov K, Schutze S, Walter J (2011) Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme. J Biol Chem 286:22711–22715
Goldfine AB, Kulkarni RN (2012) Modulation of β-cell function: a translational journey from the bench to the bedside. Diabetes Obes Metab 14(Suppl 3):152–160
Gual P, Gremeaux T, Gonzalez T, Marchand-Brustel Y, Tanti JF (2003) MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia 46:1532–1542
Gual P, Marchand-Brustel Y, Tanti JF (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99–109
Guillen C, Navarro P, Robledo M, Valverde AM, Benito M (2006) Differential mitogenic signaling in insulin receptor-deficient fetal pancreatic β-cells. Endocrinol 147:1959–1968
Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O’Connell PJ, Gonzalez FJ, Kahn CR (2005) Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337–349
Hagiwara S, Sakurai T, Tashiro F, Hashimoto Y, Matsuda Y, Nonomura Y, Miyazaki J (1995) An inhibitory role for phosphatidylinositol 3-kinase in insulin secretion from pancreatic β cell line MIN6. Biochem Biophys Res Commun 214:51–59
Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL (1996) Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet β-cells. Diabetes 45:711–717
Häring HU (1991) The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34:848–861
Hartley D, Cooper GM (2002) Role of mTOR in the degradation of IRS-1: regulation of PP2A activity. J Cell Biochem 85:304–314
Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic β-cell proliferation. Annu Rev Cell Dev Biol 22:311–338
Hennige AM, Fritsche A, Strack V, Weigert C, Mischak H, Borboni P, Renn W, Häring HU, Kellerer M (2002) PKC ζ enhances insulin-like growth factor 1-dependent mitogenic activity in the rat clonal β cell line RIN 1046-38. Biochem Biophys Res Commun 290:85–90
Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF (2003) Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes. J Clin Invest 112:1521–1532
Hennige AM, Ozcan U, Okada T, Jhala US, Schubert M, White MF, Kulkarni RN (2005) Alterations in growth and apoptosis of IRS-1 deficient β-cells. Am J Physiol Endocrinol Metab 289:E337–E346
Hennige AM, Stefan N, Kapp K, Lehmann R, Weigert C, Beck A, Moeschel K, Mushack J, Schleicher E, Häring HU (2006) Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J 20:1206–1208
Hennige AM, Ranta F, Heinzelmann I, Düfer M, Michael D, Braumüller H, Lutz SZ, Lammers R, Drews G, Bosch F, Häring HU, Ullrich S (2010) Overexpression of kinase-negative protein kinase Cdelta in pancreatic β-cells protects mice from diet-induced glucose intolerance and β-cell dysfunction. Diabetes 59:119–127
Higashi Y, Sukhanov S, Parthasarathy S, Delafontaine P (2008) The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor. Am J Physiol Heart Circ Physiol 295:H1684–H1689
Hou N, Mogami H, Kubota-Murata C, Sun M, Takeuchi T, Torii S (2012) Preferential release of newly synthesized insulin assessed by a multi-label reporter system using pancreatic β-cell line MIN6. PLoS ONE 7:e47921
Hribal ML, Perego L, Lovari S, Andreozzi F, Menghini R, Perego C, Finzi G, Usellini L, Placidi C, Capella C, Guzzi V, Lauro D, Bertuzzi F, Davalli A, Pozza G, Pontiroli A, Federici M, Lauro R, Brunetti A, Folli F, Sesti G (2003) Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN β cell line and human islets of Langerhans. FASEB J 17:1340–1342
Hubbard SR (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16:5572–5581
Hughes KJ, Meares GP, Hansen PA, Corbett JA (2011) FoxO1 and SIRT1 regulate β-cell responses to nitric oxide. J Biol Chem 286:8338–8348
Iversen J, Miles DW (1971) Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes 20:1–9
Iype T, Francis J, Garmey JC, Schisler JC, Nesher R, Weir GC, Becker TC, Newgard CB, Griffen SC, Mirmira RG (2005) Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J Biol Chem 280:16798–16807
Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE (2001) 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276:46912–46916
Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M (2003) cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575–1580
Jiang G, Dallas-Yang Q, Liu F, Moller DE, Zhang BB (2003) Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor α (TNFα)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. J Biol Chem 278:180–186
Kaiser G, Gerst F, Michael D, Berchtold S, Friedrich B, Strutz-Seebohm N, Lang F, Häring HU, Ullrich S (2013) Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of β cell death in vitro. Diabetologia 56:1587–1595
Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, Shiraiwa T, Katakami N, Yamasaki Y, Matsuhisa M, Matsuoka TA (2008) PDX-1 and MafA play a crucial role in pancreatic β-cell differentiation and maintenance of mature β-cell function. Endocr J 55:235–252
Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A (1995) Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780–23784
Kang G, Leech CA, Chepurny OG, Coetzee WA, Holz GG (2008) Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic β-cells and rat INS-1 cells. J Physiol 586:1307–1319
Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y (2006) The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281:1091–1098
Khan FA, Goforth PB, Zhang M, Satin LS (2001) Insulin activates ATP-sensitive K+ channels in pancreatic β-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 50:2192–2198
Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL (2004) Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145:5087–5096
Khoo S, Cobb MH (1997) Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion. Proc Natl Acad Sci USA 94:5599–5604
Kishi K, Mawatari K, Sakai-Wakamatsu K, Yuasa T, Wang M, Ogura-Sawa M, Nakaya Y, Hatakeyama S, Ebina Y (2007) APS-mediated ubiquitination of the insulin receptor enhances its internalization, but does not induce its degradation. Endocr J 54:77–88
Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH III, Wright CV, White MF, Arden KC, Accili D (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839–1847
Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, Accili D (2005) FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction. Cell Metab 2:153–163
Kitamura T, Ido KY (2007) Role of FoxO Proteins in Pancreatic β Cells. Endocr J 54:507–515
Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110–125
Kobayashi M, Kikuchi O, Sasaki T, Kim HJ, Yokota-Hashimoto H, Lee YS, Amano K, Kitazumi T, Susanti VY, Kitamura YI, Kitamura T (2012) FoxO1 as a double-edged sword in the pancreas: analysis of pancreas- and β-cell-specific FoxO1 knockout mice. Am J Physiol Endocrinol Metab 302:E603–E613
Kohler CU, Olewinski M, Tannapfel A, Schmidt WE, Fritsch H, Meier JJ (2011) Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas. Am J Physiol Endocrinol Metab 300:E221–E230
Kraegen EW, Lazarus L, Campbell LV (1983) Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion. Metabolism 32:622–627
Krupp MN, Lane MD (1982) Evidence for different pathways for the degradation of insulin and insulin receptor in the chick liver cell. J Biol Chem 257:1372–1377
Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49:1880–1889
Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999a) Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339
Kulkarni RN, Winnay JN, Daniels M, Brüning JC, Flier SN, Hanahan D, Kahn CR (1999b) Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J Clin Invest 104:R69–R75
Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR (2002) β-cell-specific deletion of the IGF1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111–115
Kwak YD, Wang B, Li JJ, Wang R, Deng Q, Diao S, Chen Y, Xu R, Masliah E, Xu H, Sung JJ, Liao FF (2012) Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J Neurosci 32:10971–10981
Leibiger IB, Leibiger B, Moede T, Berggren PO (1998) Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1:933–938
Leibiger B, Wahlander K, Berggren PO, Leibiger IB (2000) Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 275:30153–30156
Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO (2001) Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol Cell 7:559–570
Leibiger IB, Leibiger B, Berggren PO (2008) Insulin signaling in the pancreatic β-cell. Annu Rev Nutr 28:233–251
Leibiger B, Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO, Leibiger IB (2010) Insulin-feedback via PI3K-C2α activated PKBα/Akt1 is required for glucose-stimulated insulin secretion. FASEB J 24:1824–1837
LeRoith D, Accili D (2008) Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nat Clin Pract Endocrinol Metab 4:164–172
Lingohr MK, Briaud I, Dickson LM, McCuaig JF, Alarcon C, Wicksteed BL, Rhodes CJ (2006) Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet β -cells. J Biol Chem 281:15884–15892
Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, Ohba M, Kuroki T, LeRoith D, Zick Y (2001) Insulin stimulates PKCζ -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 276:14459–14465
Liu YF, Herschkovitz A, Boura-Halfon S, Ronen D, Paz K, LeRoith D, Zick Y (2004) Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol Cell Biol 24:9668–9681
Longuet C, Broca C, Costes S, Hani EH, Bataille D, Dalle S (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 β-cell line and islets of Langerhans. Endocrinol 146:643–654
Lopez-Avalos MD, Duvivier-Kali VF, Xu G, Bonner-Weir S, Sharma A, Weir GC (2006) Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets. Diabetes 55:1223–1231
Luo RZ, Beniac DR, Fernandes A, Yip CC, Ottensmeyer FP (1999) Quaternary structure of the insulin-insulin receptor complex. Science 285:1077–1080
MacDonald PE, Joseph JW, Yau D, Diao J, Asghar Z, Dai F, Oudit GY, Patel MM, Backx PH, Wheeler MB (2004) Impaired glucose-stimulated insulin secretion, enhanced IP insulin tolerance and increased β-cell mass in mice lacking the p110gamma isoform of PI3-kinase. Endocrinol 145:4078–4083
MacFarlane WM, Read ML, Gilligan M, Bujalska I, Docherty K (1994) Glucose modulates the binding activity of the β-cell transcription factor IUF1 in a phosphorylation-dependent manner. Biochem J 303:625–631
MacFarlane WM, Smith SB, James RF, Clifton AD, Doza YN, Cohen P, Docherty K (1997) The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells. J Biol Chem 272:20936–20944
MacFarlane WM, McKinnon CM, Felton-Edkins ZA, Cragg H, James RF, Docherty K (1999) Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic β-cells. J Biol Chem 274:1011–1016
Malaisse WJ, Malaisse-Lagae F, Lacy PE, Wright PH (1967) Insulin secretion by isolated islets in presence of glucose, insulin and anti-insulin serum. Proc Soc Exp Biol Med 124:497–500
Marshak S, Totary H, Cerasi E, Melloul D (1996) Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA 93:15057–15062
Martinez SC, Cras-Meneur C, Bernal-Mizrachi E, Permutt MA (2006) Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet β-cell. Diabetes 55:1581–1591
Massague J, Pilch PF, Czech MP (1980) Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci USA 77:7137–7141
Melloul D, Marshak S, Cerasi E (2002) Regulation of insulin gene transcription. Diabetologia 45:309–326
Melloul D (2004) Transcription factors in islet development and physiology: role of PDX-1 in β-cell function. Ann N Y Acad Sci 1014:28–37
Menting JG, Whittaker J, Margetts MB, Whittaker LJ, Kong GK, Smith BJ, Watson CJ, Zakova L, Kletvikova E, Jiracek J, Chan SJ, Steiner DF, Dodson GG, Brzozowski AM, Weiss MA, Ward CW, Lawrence MC (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493:241–245
Moeschel K, Beck A, Weigert C, Lammers R, Kalbacher H, Voelter W, Schleicher ED, Häring HU, Lehmann R (2004) Protein kinase C-ζ-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J Biol Chem 279:25157–25163
Monami G, Emiliozzi V, Morrione A (2008) Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization. J Cell Physiol 216:426–437
Morino K, Neschen S, Bilz S, Sono S, Tsirigotis D, Reznick RM, Moore I, Nagai Y, Samuel V, Sebastian D, White M, Philbrick W, Shulman GI (2008) Muscle-specific IRS-1 Ser- > Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57:2644–2651
Neukamm SS, Toth R, Morrice N, Campbell DG, Mackintosh C, Lehmann R, Häring HU, Schleicher ED, Weigert C (2012) Identification of the amino acids 300–600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573. PLoS ONE 7:e43296
Norquay LD, D’Aquino KE, Opare-Addo LM, Kuznetsova A, Haas M, Bluestone JA, White MF (2009) Insulin receptor substrate-2 in β-cells decreases diabetes in nonobese diabetic mice. Endocrinology 150:4531–4540
Okada T, Liew CW, Hu J, Hinault C, Michael MD, Kürtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN (2007) Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104:8977–8982
Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D (2006) Role of the forkhead protein FoxO1 in β cell compensation to insulin resistance. J Clin Invest 116:775–782
O’Malley D, Shanley LJ, Harvey J (2003) Insulin inhibits rat hippocampal neurones via activation of ATP-sensitive K+ and large conductance Ca2+-activated K+ channels. Neuropharmacology 44:855–863
Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen T, Billestrup N, Halban PA (2008) Proliferation of sorted human and rat β cells. Diabetologia 51:91–100
Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL (2000) Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells. Eur Cytokine Netw 11:267–274
Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272:29911–29918
Pigeau GM, Kolic J, Ball BJ, Hoppa MB, Wang YW, Rückle T, Woo M, Manning Fox JE, MacDonald PE (2009) Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human β-cells. Diabetes 58:2084–2092
Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184
Rhodes CJ, Halban PA (1987) Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol 105:145–153
Rhodes CJ (2000) IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24:303–311
Rhodes CJ (2005) Type 2 diabetes-a matter of β-cell life and death? Science 307:380–384
Roper MG, Qian WJ, Zhang BB, Kulkarni RN, Kahn CR, Kennedy RT (2002) Effect of the insulin mimetic L-783,281 on intracellular Ca2+ and insulin secretion from pancreatic β-cells. Diabetes 51(Suppl 1):S43–S49
Rui L, Fisher TL, Thomas J, White MF (2001a) Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276:40362–40367
Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF (2001b) Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107:181–189
Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20–47
Schmitz-Peiffer C, Whitehead JP (2003) IRS-1 regulation in health and disease. IUBMB Life 55:367–374
Seino S, Bell GI (1989) Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159:312–316
Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650–1656
Shibasaki T, Sunaga Y, Fujimoto K, Kashima Y, Seino S (2004) Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis. J Biol Chem 279:7956–7961
Smith BJ, Huang K, Kong G, Chan SJ, Nakagawa S, Menting JG, Hu SQ, Whittaker J, Steiner DF, Katsoyannis PG, Ward CW, Weiss MA, Lawrence MC (2010) Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists. Proc Natl Acad Sci USA 107:6771–6776
Sodoyez JC, Sodoyez-Goffaux F, Foa PP (1969) Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans. Proc Soc Exp Biol Med 130:568–571
Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML (2000) Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3:757–758
Srinivasan S, Bernal-Mizrachi E, Ohsugi M, Permutt MA (2002) Glucose promotes pancreatic islet β-cell survival through a PI 3-kinase/Akt-signaling pathway. Am J Physiol Endocrinol Metab 283:E784–E793
Steneberg P, Bernardo L, Edfalk S, Backlund F, Lundberg L, Stenson CG, Edlund H (2013) The type 2 diabetes associated gene Ide is required for insulin secretion and suppression of α-synuclein levels in β-cells. Diabetes 62:2004–2014
Takamoto I, Terauchi Y, Kubota N, Ohsugi M, Ueki K, Kadowaki T (2008) Crucial role of insulin receptor substrate-2 in compensatory β-cell hyperplasia in response to high fat diet-induced insulin resistance. Diabetes Obes Metab 10(Suppl 4):147–156
Talchai C, Lin HV, Kitamura T, Accili D (2009) Genetic and biochemical pathways of β-cell failure in type 2 diabetes. Diabetes Obes Metab 11(Suppl 4):38–45
Taylor SI (1992) Lilly lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473–1490
Tsunekawa S, Demozay D, Briaud I, McCuaig J, Accili D, Stein R, Rhodes CJ (2011) FoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytes. Diabetes 60:2883–2891
Uhles S, Moede T, Leibiger B, Berggren PO, Leibiger IB (2003) Isoform-specific insulin receptor signaling involves different plasma membrane domains. J Cell Biol 163:1327–1337
Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756–761
van Haeften TW, Twickler TB (2004) Insulin-like growth factors and pancreas β cells. Eur J Clin Invest 34:249–255
Van Schravendijk CF, Foriers A, Van den Brande JL, Pipeleers DG (1987) Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinol 121:1784–1788
Vecchione A, Marchese A, Henry P, Rotin D, Morrione A (2003) The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol 23:3363–3372
Velloso LA, Carneiro EM, Crepaldi SC, Boschero AC, Saad MJ (1995) Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets. FEBS Lett 377:353–357
Verspohl EJ, Ammon HP (1980) Evidence for presence of insulin receptors in rat islets of Langerhans. J Clin Invest 65:1230–1237
Vogt B, Carrascosa JM, Ermel B, Ullrich A, Häring HU (1991) The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 177:1013–1018
Wang H, Brun T, Kataoka K, Sharma AJ, Wollheim CB (2007) MafA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 50:348–358
Waraich RS, Weigert C, Kalbacher H, Hennige AM, Lutz S, Häring HU, Schleicher ED, Voelter W, Lehmann R (2008) Phosphorylation of Ser357of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells. J Biol Chem 283:11226–11233
Watada H, Kajimoto Y, Miyagawa J, Hanafusa T, Hamaguchi K, Matsuoka T, Yamamoto K, Matsuzawa Y, Kawamori R, Yamasaki Y (1996) PDX-1 induces insulin and glucokinase gene expressions in αTC1 clone 6 cells in the presence of betacellulin. Diabetes 45:1826–1831
Watson ML, Macrae K, Marley AE, Hundal HS (2011) Chronic effects of palmitate overload on nutrient-induced insulin secretion and autocrine signalling in pancreatic MIN6 β cells. PLoS ONE 6:e25975
Weigert C, Hennige AM, Brischmann T, Beck A, Moeschel K, Schauble M, Brodbeck K, Häring HU, Schleicher ED, Lehmann R (2005) The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signal. J Biol Chem 280:37393–37399
Werner ED, Lee J, Hansen L, Yuan M, Shoelson SE (2004) Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem 279:35298–35305
White MF, Maron R, Kahn CR (1985) Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318:183–186
White MF (2006) Regulating insulin signaling and β-cell function through IRS proteins. Can J Physiol Pharmacol 84:725–737
Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904
Wu H, MacFarlane WM, Tadayyon M, Arch JR, James RF, Docherty K (1999) Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic β cells. Biochem J 344:813–818
Xuan S, Kitamura T, Nakae J, Politi K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, Efstratiadis A (2002) Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor. J Clin Invest 110:1011–1019
Yasui S, Mawatari K, Kawano T, Morizumi R, Hamamoto A, Furukawa H, Koyama K, Nakamura A, Hattori A, Nakano M, Harada N, Hosaka T, Takahashi A, Oshita S, Nakaya Y (2008) Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cells. J Vasc Res 45:233–243
Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S (2003) Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308
Zawalich WS, Zawalich KC (2000) A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats. Endocrinology 141:3287–3295
Zhao AZ, Zhao H, Teague J, Fujimoto W, Beavo JA (1997) Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci USA 94:3223–3228
Zhao J, Li L, Leissring MA (2009) Insulin-degrading enzyme is exported via an unconventional protein secretion pathway. Mol Neurodegener 4:4
Zhu J, Kahn CR (1997) Analysis of a peptide hormone-receptor interaction in the yeast two-hybrid system. Proc Natl Acad Sci USA 94:13063–13068
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Ullrich, S. (2015). IGF-1 and Insulin-Receptor Signalling in Insulin-Secreting Cells: From Function to Survival. In: Islam, M. (eds) Islets of Langerhans. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6686-0_26
Download citation
DOI: https://doi.org/10.1007/978-94-007-6686-0_26
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6685-3
Online ISBN: 978-94-007-6686-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences